Overexpression of Gpx4 leads to reduced tumor growth of weakly tumorigenic L929 fibrosarcoma cells and pancreatic cancer cells [87], possibly mediated by inhibition of NF-κB activation [88]. The gene discussed is NFKB1; the disease is neoplasm.